NEUROPACE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
NEUROPACE, INC. (NPCE) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 2.27 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2026-08-11
- NEUROPACE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2026-06-30 was 2.27K shares, a 95.11% decline year-over-year.
- NEUROPACE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2026-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- NEUROPACE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-12-31 was 1.55K shares, a 95.11% decline year-over-year.
- NEUROPACE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-09-30 was 115.00 shares, a 99.65% decline year-over-year.
- NEUROPACE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2025 was 56.22K shares, a 67.78% decline from fiscal 2024.
- NEUROPACE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2024 was 174.49K shares, a 73.68% decline from fiscal 2023.
- NEUROPACE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2023 was 663.08K shares, a 429.79% increase from fiscal 2022.
- NEUROPACE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2022 was 125.16K shares, a 48.10% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 2.27K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | 2.27K shares 10-Q · filed 2026-08-11 | 3.82K shares derived: sum of 3 quarters · filed 2026-08-11 | 3.94K shares derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-12 | 1.55K shares derived: sum of 2 quarters · filed 2026-05-12 | 1.67K shares derived: sum of 3 quarters · filed 2026-05-12 | 48.04K shares derived: sum of 4 quarters · filed 2026-05-12 |
| 2025-12-31 | 1.55K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | 1.67K shares derived: sum of 2 quarters · filed 2026-03-03 | 48.04K shares derived: sum of 3 quarters · filed 2026-03-03 | 56.22K shares 10-K · filed 2026-03-03 |
| 2025-09-30 | 115.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | 46.49K shares derived: sum of 2 quarters · filed 2025-11-04 | 54.66K shares 10-Q · filed 2025-11-04 | 86.47K shares derived: sum of 4 quarters · filed 2025-11-04 |
| 2025-06-30 | 46.37K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | 54.55K shares 10-Q · filed 2025-08-12 | 86.35K shares derived: sum of 3 quarters · filed 2025-08-12 | 119.63K shares derived: sum of 4 quarters · filed 2025-08-12 |
| 2025-03-31 | 8.17K shares 10-Q · filed 2025-05-13 | 39.98K shares derived: sum of 2 quarters · filed 2025-05-13 | 73.26K shares derived: sum of 3 quarters · filed 2025-05-13 | 132.04K shares derived: sum of 4 quarters · filed 2025-05-13 |
| 2024-12-31 | 31.80K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | 65.08K shares derived: sum of 2 quarters · filed 2025-03-04 | 123.87K shares derived: sum of 3 quarters · filed 2025-03-04 | 174.49K shares 10-K · filed 2025-03-04 |
| 2024-09-30 | 33.28K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 92.07K shares derived: sum of 2 quarters · filed 2024-11-12 | 142.69K shares 10-Q · filed 2024-11-12 | 143.12K shares derived: sum of 4 quarters · filed 2025-03-04 |
| 2024-06-30 | 58.79K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | 109.41K shares 10-Q · filed 2024-08-13 | 109.84K shares derived: sum of 3 quarters · filed 2025-03-04 | 650.35K shares derived: sum of 4 quarters · filed 2025-03-04 |
| 2024-03-31 | 50.62K shares 10-Q · filed 2024-05-08 | 51.05K shares derived: sum of 2 quarters · filed 2025-03-04 | 591.56K shares derived: sum of 3 quarters · filed 2025-03-04 | 695.80K shares derived: sum of 4 quarters · filed 2025-03-04 |
| 2023-12-31 | 433.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | 540.93K shares derived: sum of 2 quarters · filed 2025-03-04 | 645.18K shares derived: sum of 3 quarters · filed 2025-03-04 | 663.08K shares 10-K · filed 2025-03-04 |
| 2023-09-30 | 540.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | 644.74K shares derived: sum of 2 quarters · filed 2023-11-06 | 662.64K shares 10-Q · filed 2023-11-06 | 694.57K shares derived: sum of 4 quarters · filed 2024-03-05 |
| 2023-06-30 | 104.24K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | 122.14K shares 10-Q · filed 2023-08-08 | 154.07K shares derived: sum of 3 quarters · filed 2024-03-05 | 178.77K shares derived: sum of 4 quarters · filed 2024-03-05 |
| 2023-03-31 | 17.90K shares 10-Q · filed 2023-05-04 | 49.82K shares derived: sum of 2 quarters · filed 2024-03-05 | 74.53K shares derived: sum of 3 quarters · filed 2024-03-05 | 105.74K shares derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-12-31 | 31.93K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | 56.63K shares derived: sum of 2 quarters · filed 2024-03-05 | 87.84K shares derived: sum of 3 quarters · filed 2024-03-05 | 125.16K shares 10-K · filed 2024-03-05 |
| 2022-09-30 | 24.70K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | 55.91K shares derived: sum of 2 quarters · filed 2022-11-08 | 93.23K shares 10-Q · filed 2022-11-08 | 120.65K shares derived: sum of 4 quarters · filed 2023-03-02 |
| 2022-06-30 | 31.21K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | 68.53K shares 10-Q · filed 2022-08-11 | 95.94K shares derived: sum of 3 quarters · filed 2023-03-02 | 112.56K shares derived: sum of 4 quarters · filed 2023-03-02 |
| 2022-03-31 | 37.32K shares 10-Q · filed 2022-05-12 | 64.74K shares derived: sum of 2 quarters · filed 2023-03-02 | 81.35K shares derived: sum of 3 quarters · filed 2023-03-02 | 84.06K shares derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-12-31 | 27.42K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | 44.03K shares derived: sum of 2 quarters · filed 2023-03-02 | 46.74K shares derived: sum of 3 quarters · filed 2023-03-02 | 84.51K shares 10-K · filed 2023-03-02 |
| 2021-09-30 | 16.62K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | 19.32K shares derived: sum of 2 quarters · filed 2021-11-10 | 57.09K shares 10-Q · filed 2021-11-10 | |
| 2021-06-30 | 2.70K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | 40.47K shares 10-Q · filed 2021-08-12 | ||
| 2021-03-31 | 37.77K shares 10-Q · filed 2021-06-03 | |||
| 2020-12-31 | 183.01K shares 10-K · filed 2022-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |